Short answer
MYRIAD GENETICS INC (MYGN) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). One-time retention options target executive continuity during operational-efficiency and financial-performance initiatives.
MYRIAD GENETICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- One-time retention options target executive continuity during operational-efficiency and financial-performance initiatives
- CFO Benjamin Wheeler awarded options for 121,379 shares
- COO Mark Verratti awarded options for 146,933 shares
- CSO Dale Muzzey awarded options for 92,632 shares
- Three-year cliff vesting, exercise price set at grant-date closing price, creating a long-term retention commitment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MYRIAD GENETICS INC 8-K filings
Get the next MYGN 8-K as it lands
Follow MYGN for push alerts, or ask the research agent what this filing means.